# FDA Inspection 1136336 - Mayaguez Medical Center Inc - February 18, 2021

Source: https://www.keypedia.com/records/fda_inspections/mayaguez-medical-center-inc/8b821b2a-1924-4103-b57f-883c90a2b4c4
Source feed: FDA_Inspections

> FDA Inspection 1136336 for Mayaguez Medical Center Inc on February 18, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1136336
- Company Name: Mayaguez Medical Center Inc
- Inspection Date: 2021-02-18
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1257618 - 2024-12-12](https://www.keypedia.com/records/fda_inspections/mayaguez-medical-center-inc/4a2c176a-f337-4e4a-b9d0-801c55f79717)
- [FDA Inspection 1257618 - 2024-12-12](https://www.keypedia.com/records/fda_inspections/mayaguez-medical-center-inc/2ff56353-afcc-4894-a1bf-b790fe3fe7d5)
- [FDA Inspection 1037950 - 2017-12-20](https://www.keypedia.com/records/fda_inspections/mayaguez-medical-center-inc/ecf6e159-4c38-4947-8d92-2e66838e3626)
- [FDA Inspection 951621 - 2015-12-10](https://www.keypedia.com/records/fda_inspections/mayaguez-medical-center-inc/a347a45f-6af5-41c4-9ca3-979ee052f19a)
- [FDA Inspection 870105 - 2014-03-07](https://www.keypedia.com/records/fda_inspections/mayaguez-medical-center-inc/d0f484b8-3429-43df-95f1-1120333d1928)

Company: https://www.keypedia.com/companies/mayaguez-medical-center-inc/6b0f7947-123d-4e7d-be05-d087ec2e2b85

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d